Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE)
Back
7 Feb 2025
2:15 p.m.
2:45 p.m.
Rajiv
Agarwal
Oral Abstract Presenter
United States